LRRK2 was the second most frequent finding in our cohort of monogenic PD; the frequency of the p.Gly2019Ser (G2019S) variant was 1.8% in our cohort, consistently with previous Italian data [27], but lower than other Mediterranean countries [22, 28] and more similar to continental Europe. This evidence concerns the gene LRRK2 and Parkinson disease.